AU3410099A - Pharmaceutical compositions containing melatonin inclusion complexes - Google Patents
Pharmaceutical compositions containing melatonin inclusion complexesInfo
- Publication number
- AU3410099A AU3410099A AU34100/99A AU3410099A AU3410099A AU 3410099 A AU3410099 A AU 3410099A AU 34100/99 A AU34100/99 A AU 34100/99A AU 3410099 A AU3410099 A AU 3410099A AU 3410099 A AU3410099 A AU 3410099A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- inclusion complexes
- containing melatonin
- melatonin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI98A0510 | 1998-03-13 | ||
| IT98MI000510A IT1298731B1 (it) | 1998-03-13 | 1998-03-13 | Composizioni farmaceutiche contenenti complessi di inclusione con melatonina |
| PCT/EP1999/001539 WO1999047175A1 (fr) | 1998-03-13 | 1999-03-10 | Compositions pharmaceutiques contenant des complexes d'inclusion de melatonine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3410099A true AU3410099A (en) | 1999-10-11 |
Family
ID=11379301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU34100/99A Abandoned AU3410099A (en) | 1998-03-13 | 1999-03-10 | Pharmaceutical compositions containing melatonin inclusion complexes |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU3410099A (fr) |
| IT (1) | IT1298731B1 (fr) |
| WO (1) | WO1999047175A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101677994B (zh) * | 2007-04-11 | 2015-07-22 | 药品生产公司 | 褪黑激素片剂及制备和使用的方法 |
| WO2012103411A2 (fr) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Composition de mélatonine à libération contrôlée et procédés associés |
| US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| ITMI20112042A1 (it) * | 2011-11-10 | 2013-05-11 | Eratech S R L | Polvere da ricostituire prima dell'uso comprendente melatonina e preparazione iniettabile ottenibile da tale polvere. |
| US20180050019A1 (en) * | 2015-03-06 | 2018-02-22 | Repoceuticals Aps | Melatonin for Preventing and Treating Radiation Vaginitis and Proctitis |
| NL2015272B1 (en) | 2015-08-05 | 2017-05-02 | Versailles B V | Melatonin formulations and methods for preparation and use. |
| ITUB20156299A1 (it) * | 2015-12-03 | 2017-06-03 | S B M S R L | Prodotto comprendente collagene e almeno un farmaco amorfo micronizzato, procedimento per la sua preparazione e relativi usi in campo medico. |
| WO2019038586A1 (fr) | 2017-08-19 | 2019-02-28 | Ftf Pharma Private Limited | Composition pharmaceutique de mélatonine |
| EP3705117A1 (fr) | 2019-03-05 | 2020-09-09 | Tradichem Industrial Services, S.L. | Mélatonine ayant une meilleure solubilité dans l'eau, sa préparation et ses utilisations |
| WO2021038601A1 (fr) | 2019-08-30 | 2021-03-04 | Vijayendrakumar Virendrakumarji Redasani | Compositions pharmaceutiques liquides de mélatonine pour administration orale et parentérale |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2264718C (fr) * | 1996-09-01 | 2006-05-30 | Pharmos Corporation | Coprecipites solides augmentant la biodisponibilite de substances lipophiles |
| EP0867181A1 (fr) * | 1997-03-26 | 1998-09-30 | Franciscus Wilhelmus Henricus Maria Merkus | Composition nasale de mélatonine |
| CN1112184C (zh) * | 1998-04-13 | 2003-06-25 | 广州市美乐健生物技术有限公司 | 褪黑素缓释制剂及其生产工艺 |
-
1998
- 1998-03-13 IT IT98MI000510A patent/IT1298731B1/it active IP Right Grant
-
1999
- 1999-03-10 AU AU34100/99A patent/AU3410099A/en not_active Abandoned
- 1999-03-10 WO PCT/EP1999/001539 patent/WO1999047175A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| IT1298731B1 (it) | 2000-02-02 |
| WO1999047175A1 (fr) | 1999-09-23 |
| ITMI980510A1 (it) | 1999-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103256A3 (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds | |
| IL133293A0 (en) | Pharmaceutical compositions comprising cyclodextrins | |
| IL147970A0 (en) | Pharmaceutical compositions containing tripeptides | |
| AU3192700A (en) | Medicinal compositions | |
| AU6740298A (en) | Pharmaceutical composition | |
| AU4413299A (en) | Stabilized pharmaceutical compositions | |
| IL145290A0 (en) | Pharmaceutical compositions comprising complexes | |
| AU1574900A (en) | Pharmaceutical compositions containing insulin | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| AU3556400A (en) | Pharmaceutical compositions | |
| AU2005300A (en) | Medicinal compositions | |
| AU1887401A (en) | Medicinal composition | |
| AU8107998A (en) | Pharmaceutical compositions | |
| AU3976800A (en) | Antiperspirant compositions | |
| AU6370299A (en) | Pharmaceutical compositions containing tetrahydroisoquinoline compounds | |
| AU7904998A (en) | Pharmaceutical composition containing peptichemio | |
| IL142534A0 (en) | Pharmaceutical compositions containing an antigen-adjuvent | |
| AU6464098A (en) | Dental composition | |
| AU3410099A (en) | Pharmaceutical compositions containing melatonin inclusion complexes | |
| AU6460400A (en) | Pharmaceutical compositions | |
| AU5326298A (en) | Pharmaceutical compositions containing N-sulphonylindoline derivatives | |
| AU9343098A (en) | Pharmaceutical composition | |
| AU1044799A (en) | Pharmaceutical composition containing zafirlukast | |
| AU6460200A (en) | Pharmaceutical compositions | |
| AUPP332898A0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |